Discoveries Point to More Powerful Cancer Treatments, Fewer Side Effects
Thursday, February 27, 2014 - 12:30
in Health & Medicine
Alexey Ryazanov of Rutgers Robert Wood Johnson Medical School, who first identified the eEF2K enzyme a quarter century ago, has published new research in Developmental Cell adding evidence that inhibition of eEF2K would enhance the benefits chemo and radiation therapy by sharply reducing death of healthy cells and accompanying side effects.
